Aspirin or dipyridamole individually prevent lipid accumulation in primate vein bypass grafts
Authors:
- Lawrence E. BoerboomLBLawrence E. Boerboom
- Gordon N. OlingerGOGordon N. Olinger
- Lawrence I. BonchekLBLawrence I. Bonchek
- Ilhan I. GunayIGIlhan I. Gunay
- Ahmed H. KissebahAKAhmed H. Kissebah
- 1 February 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (5) , 556-559
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Prevention of lipid accumulation in experimental vein bypass grafts by antiplatelet therapy.Circulation, 1982
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirinThe American Journal of Cardiology, 1979
- Antiplatelet TherapyNew England Journal of Medicine, 1978
- Antiplatelet TherapyNew England Journal of Medicine, 1978
- Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts.Circulation, 1977
- Vein graft patency and intimal proliferation after aortocoronary bypass: Early and long-term angiopathologic correlationsThe American Journal of Cardiology, 1976
- Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts.Circulation, 1976
- Radioimmunoassay of human plasma apolipoproteinsAtherosclerosis, 1975